Immediate Impact

2 by Nobel laureates 1 from Science/Nature 66 hit
Sub-graph 1 of 22

Citing Papers

Changing etiology and epidemiology of hepatocellular carcinoma: Asia and worldwide
2024 Hit
Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial
2024 Hit
2 intermediate papers

Works of Susumu Imoto being referenced

Usefulness of Cytokeratin-18M65 in Diagnosing Non-Alcoholic Steatohepatitis in Japanese Population
2015
Comparison of Daclatasvir and Asunaprevir for Chronic HCV 1b Infection with Telaprevir and Simeprevir plus Peginterferon and Ribavirin, with a Focus on the Prevention of Occurrence and Recurrence of Hepatocellular Carcinoma
2015

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Susumu Imoto 378 320 80 54 42 55 493
Fumitake Amemiya 390 1.0× 336 1.1× 30 0.4× 41 0.8× 72 1.7× 34 544
Meyer zum Büschenfelde Kh 175 0.5× 208 0.7× 61 0.8× 39 0.7× 30 0.7× 55 417
Kiyoshi Furuta 219 0.6× 228 0.7× 40 0.5× 43 0.8× 18 0.4× 28 469
Makoto Kuboki 383 1.0× 283 0.9× 38 0.5× 97 1.8× 21 0.5× 32 429
Kiyohide Kioka 334 0.9× 282 0.9× 27 0.3× 49 0.9× 7 0.2× 58 417
Bülent Baran 215 0.6× 295 0.9× 27 0.3× 134 2.5× 14 0.3× 56 543
Leona Dold 251 0.7× 246 0.8× 19 0.2× 50 0.9× 29 0.7× 34 503
Hiromi Kan 271 0.7× 313 1.0× 15 0.2× 77 1.4× 12 0.3× 32 456
Ken Watanabe 226 0.6× 101 0.3× 32 0.4× 158 2.9× 50 1.2× 44 510
J. L. Touraine 114 0.3× 178 0.6× 18 0.2× 79 1.5× 17 0.4× 53 536

All Works

Loading papers...

Rankless by CCL
2026